美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
42283 A III 2025/07/30 VINAYAK PLASTIC INDUSTRIES LAMINATED TUBES
42297 A II 2025/07/30 SICHUAN GOWELL PHARMACEUTICAL CO LTD SUCROFERRIC OXYHYDROXIDE
42309 A II 2025/07/30 ZHEJIANG HISUN PHARMACEUTICAL CO LTD LETERMOVIR
42310 A II 2025/07/30 PIRAMAL PHARMA LTD LANREOTIDE
42320 A II 2025/07/30 ANHUI POLY PHARM CO LTD IOVERSOL USP
42325 A II 2025/07/30 SICHUAN XIELI PHARMACEUTICAL CO LTD CYTISINE
42356 A II 2025/07/30 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD PERINDOPRIL ARGININE
42061 A II 2025/07/29 DR REDDYS LABORATORIES LTD EDOXABAN TOSYLATE MONOHYDRATE
41319 A II 2025/07/29 DASAMI LAB PRIVATE LTD THEOPHYLLINE ANHYDROUS USP
42139 A II 2025/07/29 ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD FERRIC CARBOXYMALTOSE
42201 A II 2025/07/29 IPCA LABORATORIES LTD ATOVAQUONE USP
42238 A II 2025/07/29 HONOUR LAB LTD MARALIXIBAT CHLORIDE
42278 A II 2025/07/29 DIPHARMA SA MIGALASTAT HYDROCHLORIDE
42281 A II 2025/07/29 AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) EDOXABAN TOSYLATE MONOHYDRATE
42285 A II 2025/07/29 AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) ROSUVASTATIN CALCIUM USP PROCESS-II
42298 A II 2025/07/29 HETERO LABS LTD ASCIMINIB HYDROCHLORIDE PREMIX
41892 A IV 2025/07/28 CORDEN PHARMA SWITZERLAND LLC LP-01 IONIZABLE CATIONIC LIPID
42103 A IV 2025/07/27 NANJING ABYDOS PHARMA TECHNOLOGY CO LTD SALCAPROZATE SODIUM
42314 A IV 2025/07/27 ZIBO QIANHUI BIOLOGICAL TECHNOLOGY CO LTD BETADEX SULFOBUTYL ETHER SODIUM, PROCESS II
42075 A II 2025/07/25 SHANDONG NEW TIME PHARMACEUTICAL CO LTD DALFAMPRIDINE

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files